PlainRecalls

Wells Pharma of Houston LLC

Compiled from official public sources by the publisher.

8 recalls on record · Latest: May 6, 2026

Subscribe to new Wells Pharma of Houston LLC recalls (RSS)

Agency notice ledger

Federal filing book Wells Pharma of Houston LLC LIGHT-BOOK · SINGLE-AGENCY

#1,847 of 14,151 · 8 notices · 0.008% archive

  • BOOK 8 notices
  • RANK #1,847 of 14,151
  • SHARE 0.008% archive
  • AGENCY FDA Drug (8)
  • CAT drugs
  • CATS 1 category
  • LATEST May 6, 2026
  • PHOTO Ab Sciex

Nearest notice-volume peer: Ab Sciex (0 notice gap)

Wells Pharma of Houston LLC accounts for about 0.008% of the 104,423-notice archive on 8 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Wells Pharma of Houston LLC sits among 14,151 recalling firms

Wells Pharma of Houston LLC ranks 1,847th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Wells Pharma of Houston LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

8 1847th of 14151 higher than 12,296 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Wells Pharma of Houston LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Wells Pharma of Houston LLC holds about 0.008% of archive notices alongside 8 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate May 6, 2026

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.
FDA Drug Moderate May 6, 2026

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
FDA Drug Moderate May 6, 2026

fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.
FDA Drug Moderate May 6, 2026

fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.
FDA Drug Moderate May 6, 2026

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
FDA Drug Moderate May 6, 2026

Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03
FDA Drug Moderate May 6, 2026

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
FDA Drug Moderate Dec 13, 2023

ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

Wells Pharma of Houston LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (8 here).

Ab Sciex 8 Acumedia Manufacturers, Inc. 8 Adept Medical Ltd 8 Aju Pharm Co., Ltd. 8 Ambriola Co., Inc., The 8

Frequently Asked Questions

How many federal recall notices name Wells Pharma of Houston LLC? ▼
PlainRecalls indexes 8 distinct federal recall events naming Wells Pharma of Houston LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Wells Pharma of Houston LLC sit among other recalling firms? ▼
Wells Pharma of Houston LLC ranks #1,847 of 14,151 by distinct recall-event count among 14,151 firms in this archive (87th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Wells Pharma of Houston LLC's notices? ▼
FDA Drug accounts for 8 of this firm's 8 indexed notices.
What product category dominates Wells Pharma of Houston LLC's filing book? ▼
Filings for Wells Pharma of Houston LLC span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Wells Pharma of Houston LLC: 8 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Wells Pharma of Houston LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026